Aldisa SR Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Loratadine 5 mg, pseudoephedrine sulfate 120 mg

Indications/Uses

Relief of symptoms associated w/ allergic rhinitis & common cold including nasal congestion, sneezing, rhinorrhea, pruritus & lacrimation.

Dosage/Direction for Use

Adult & childn ≥12 yr 1 cap twice daily.

Administration

May be taken with or without food: Swallow whole, do not chew/crush.

Contraindications

Patients on or w/ in 14 days after MAOI therapy discontinuation; narrow-angle glaucoma, urinary retention, severe HTN, severe CAD, hyperthyroidism.

Special Precautions

Glaucoma, peptic ulcer stenosis, pyloroduodenal obstruction, CV disease, prostatic hypertrophy, HTN, increased IOP or DM. Elderly.

Adverse Reactions

Insomnia, dry mouth, headache & somnolence. Posterior reversible encephalopathy syndrome (PRES) & reversible cerebral vasoconstriction syndrome (RCVS) w/ symptoms eg, sudden severe headache, nausea, vomiting, confusion, seizures &/or visual disturbances.

View ADR Reporting Link

Drug Interactions

β-blockers, methyldopa, mecamylamine, reserpine, veratrum alkaloids, digitalis, ketoconazole, erythromycin, cimetidine.

MIMS Class

Cough & Cold Preparations / Antihistamines & Antiallergics

ATC Classification

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic sympathomimetic preparations used as nasal decongestants.

Regulatory Classification

Presentation/Packing

Form

Aldisa SR cap

Packing/Price

5 × 10's (Rp5,950/SR cap, Rp297,500/boks)

Aldisa SR

loratadine + pseudoephedrine

Manufacturer:

Sanbe